Latest Articles

In this interview with Professors Itai Yanai and Martin Lercher, explore how night science brings creativity, ideation and collaboration back into the heart of modern science.

Once seen purely as a sports supplement, creatine is now a focus of clinical and public health research. Experts highlight its proven role in muscle performance and emerging potential in brain health, aging and metabolic disorders.

Scientists have tested whether the diabetes drug metformin could improve survival and/or reduce the severity of common and unpleasant side effects associated with the treatment of metastatic prostate cancer.

A Q&A with Dr. Corentin J. Gosling, lead author of an umbrella review, explores the evidence behind complementary and alternative autism therapies. Covering 200 trials and 10,000 participants, the review found no strong proof of benefit.

Explore types of therapeutic proteins, design strategies and the production methods used in treating cancer, autoimmune diseases and more.

Shonali Paul, COO at CloudLIMS, discusses what the FDA Modernization Act means for clinical research labs, the rise of alternative test methods and the role that a LIMS plays in ensuring compliance and seamless workflows.

Discover how digital chemistry is shaping the future of drug and materials discovery through automation and scalable innovation.

We spoke with Dr. Niranjan Bose, managing director (Health & Life Sciences Strategy) at Gates Ventures, about a new $1M prize to advance dementia research using artificial intelligence.

For decades, drug discovery has focused on inhibiting enzymes to treat disease. Yet vast swathes of the proteome remain “undruggable” by traditional approaches. Molecular glues offer a way to remove harmful proteins from cells entirely.

Discover how ABC transporters could offer a targeted approach to tackle drug-resistant bacteria and combat antimicrobial resistance.